Thrombolytic therapy of renal vein thrombi and follow-up.
Wu
Z L
ZL
Zhou
K R
KR
Liao
L T
LT
D000328:Adult; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000032:analysis; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000150:complications; D012078:Renal Artery Obstruction / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
D001779:Blood Coagulation Factors; D014859:Warfarin; D004176:Dipyridamole; D014568:Urokinase-Type Plasminogen Activator